Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Juran

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Gastroenterology|February 7, 2015
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisNatalie L Berntsen, Olav Klingenberg, Brian D Juran, et al.
Hepatology (Baltimore, Md.)|August 8, 2007
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosisKonstantinos N Lazaridis, Brian D Juran, Gwen M Boe, et al.
Scientific Reports|July 30, 2020
Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitisJin Sung Jang, Brian D Juran, Kevin Y Cunningham, et al.
Hepatology Communications|November 26, 2021
High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver DiseasesDouglas I Walker, Brian D Juran, Angela C Cheung, et al.
Hepatology Communications|July 18, 2024
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver diseaseBrian D Juran, Bryan M McCauley, Elizabeth J Atkinson, et al.
Hepatology (Baltimore, Md.)|May 10, 2018
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine LearningJohn E Eaton, Mette Vesterhus, Bryan M McCauley, et al.
Cancer Medicine|August 16, 2015
Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinomaRoongruedee Chaiteerakij, Brian D Juran, Mohammed M Aboelsoud, et al.
Epigenomics|April 27, 2022
DNA methylation profile of liver tissue in end-stage cholestatic liver diseaseAngela C Cheung, Brian D Juran, Erik M Schlicht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct diseaseSigrid Naess, Einar Björnsson, Jarl A Anmarkrud, et al.
Hepatology Communications|September 14, 2021
Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary DifferentiationNidhi Jalan-Sakrikar, Thiago M De Assuncao, Amaia Navarro-Corcuera, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Gastroenterology|February 7, 2015
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisNatalie L Berntsen, Olav Klingenberg, Brian D Juran, et al.
Hepatology (Baltimore, Md.)|August 8, 2007
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosisKonstantinos N Lazaridis, Brian D Juran, Gwen M Boe, et al.
Scientific Reports|July 30, 2020
Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitisJin Sung Jang, Brian D Juran, Kevin Y Cunningham, et al.
Hepatology Communications|November 26, 2021
High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver DiseasesDouglas I Walker, Brian D Juran, Angela C Cheung, et al.
Hepatology Communications|July 18, 2024
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver diseaseBrian D Juran, Bryan M McCauley, Elizabeth J Atkinson, et al.
Hepatology (Baltimore, Md.)|May 10, 2018
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine LearningJohn E Eaton, Mette Vesterhus, Bryan M McCauley, et al.
Cancer Medicine|August 16, 2015
Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinomaRoongruedee Chaiteerakij, Brian D Juran, Mohammed M Aboelsoud, et al.
Epigenomics|April 27, 2022
DNA methylation profile of liver tissue in end-stage cholestatic liver diseaseAngela C Cheung, Brian D Juran, Erik M Schlicht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct diseaseSigrid Naess, Einar Björnsson, Jarl A Anmarkrud, et al.
Hepatology Communications|September 14, 2021
Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary DifferentiationNidhi Jalan-Sakrikar, Thiago M De Assuncao, Amaia Navarro-Corcuera, et al.
Pageof 6